Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Scadden Insider Profile
4 Followers
David Scadden, Director at Agios Pharma, holds 15.48K shares in Agios Pharma (Ticker: AGIO), holds 808.67K shares in Dianthus Therapeutics (Ticker: DNTH), holds ― shares in Editas Medicine (Ticker: EDIT).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-8.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Scadden holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 27, 2018 - Jun 27, 2019
Return:+4.90%
The most profitable trade made by David Scadden
David Scadden's Trading History
Agios Pharma
Dec 13, 2024
Director
Uninformative Buy
3.62K
$545.31K
Dianthus Therapeutics
Jun 27, 2018
Director
Uninformative Buy
―
$19.14M
Editas Medicine
―
Director
―
―
Carisma Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see David Scadden's performance on stock
You May Also Like
David Scadden insider profile FAQ
What is the percentage of profitable transactions made by David Scadden?
The percentage of profitable transactions made by David Scadden is 50%.
What is the average return per transaction made by David Scadden?
The average return per transaction made by David Scadden is -8.60%.
What stocks does David Scadden hold?
David Scadden holds: AGIO, DNTH, EDIT, CARM stocks.
What was David Scadden’s latest transaction?
David Scadden latest transaction was an Uninformative Buy of $3.62K.
What was David Scadden's most profitable transaction?
David Scadden’s most profitable transaction was an Informative Buy of DNTH stock on June 27, 2018. The return on the trade was 4.90%.
What is David Scadden's role in Agios Pharma?
David Scadden's role in Agios Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.